# High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism.

Study · id `cardio:ct-nct07381712` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07381712](<https://clinicaltrials.gov/study/NCT07381712>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07381712

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.

## Technical summary

Registry record NCT07381712. Randomized; single masking; primary purpose treatment. Start 2025-10-01 (actual); primary completion 2026-10-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT07381712, source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)
- Started: 2025-10-01 (actual) (ClinicalTrials.gov record NCT07381712, source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)
- Primary completion: 2026-10-30 (anticipated) (ClinicalTrials.gov record NCT07381712, source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)
- Completion: 2026-11-30 (anticipated) (ClinicalTrials.gov record NCT07381712, source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)
- Countries: Egypt (ClinicalTrials.gov record NCT07381712, source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07381712-2026-02-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism.
- Condition: Pulmonary Embolism
- Intervention (Device): High-Flow Nasal Cannula (HFNC)
- Intervention (Device): Non-Invasive Ventilation (NIV)
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: 8d74cef9bac08240abbeefb7c999c4e868efa722c3561c6aa77500d80ce01c50
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
